Housecall Pro Integrates with AI Mode in Google Search to Turn Home Service Searches into Booked Jobs 
Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17 
The 34th Hong Kong International Optical Fair opens today 
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo Treatment 
Payment Cards Group (A3A PayTech) Joins HKMA’s Agentic Finance Expert Group Tilray Medical Launches Sleep-Oriented CBN Night Oil for Medical Cannabis Patients in Canada
Aphria Medical CBN Oil New Aphria CBN Night Oil formulated for night-time use LEAMINGTON, Ontario,…
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders
TORONTO, June 07, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP;…
Medicenna to Announce Fiscal Year 2022 Financial Results and Operational Highlights on Wednesday, June 22, 2022
TORONTO and HOUSTON, June 07, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical-stage pharmaceutical…
Inozyme Pharma Appoints Kurt Gunter, M.D., as Chief Medical Officer
BOSTON, June 07, 2022 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare…
Novo Nordisk A/S:
Novo Nordisk – major shareholder announcement Bagsværd, Denmark, 7 June 2022 – Novo Nordisk today…
MetasTx LLC Raises Funds, Engages Manufacturing Partner, And Advances Phase One Development
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) — MetasTx LLC is driven to create…
Skye Bioscience Expands Cannabinoid Pharmaceutical Innovation Program with Leading Cannabinoid Medicinal Chemistry Groups
New collaborations focused on building library of novel cannabinoid derivatives and small molecules capable of…
ASLAN Pharmaceuticals Initiates Scientific Collaboration to Investigate the Distinct Role of IL-13 Receptor Signaling in Atopic Dermatitis
MENLO PARK, Calif. and SINGAPORE, June 07, 2022 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ: ASLN),…
Court Sanction of the Scheme of Arrangement
Acacia Pharma Group PLC THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AND REGULATED INFORMATION NOT FOR RELEASE,…
Athira Pharma Announces Formation of Scientific Advisory Board Comprised of Renowned Leaders in Neurology Research
BOTHELL, Wash., June 07, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late…
BioXcel Therapeutics to Participate at Two Upcoming Investor Conferences
NEW HAVEN, Conn., June 07, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer
TUEBINGEN, Germany and HOUSTON and CAMBRIDGE, Mass., June 07, 2022 (GLOBE NEWSWIRE) — Immatics N.V….
Apellis and Sobi Announce First Patient Dosed in Phase 3 VALIANT Study of Pegcetacoplan for IC-MPGN and C3G, Rare Kidney Diseases with High Unmet Medical Need
WALTHAM, Mass. and STOCKHOLM, Sweden, June 07, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq:…
Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
PITTSBURGH, June 07, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the…
PharmaTher Announces Positive Results from Study of KETABET™ for Depression
KETABET™ (Ketamine and Betaine) shown effectiveness as measured by the Clinician Administered Dissociative States Scale…
Annexon Biosciences Reports Phase 2 Clinical Trial Results Demonstrating Upstream Classical Complement Inhibition Associated with Clinical Benefit in Huntington’s Disease
ANX005 Demonstrated Full C1q Target Inhibition and Was Generally Well-Tolerated Disease Progression Stabilized in Overall…
Veru Submits Emergency Use Authorization (EUA) Application to U.S. FDA for Sabizabulin, its Novel, Oral Antiviral and Anti-Inflammatory Drug Candidate for Hospitalized COVID-19 Patients at High Risk for ARDS
— The EUA Submission Follows Positive Phase 3 COVID-19 Clinical Trial in which Sabizabulin Demonstrated…
Clover to Participate in Credit Suisse Asia Healthcare Corporate Day
SHANGHAI, China, June 07, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…
AvePoint Solutions Now Available on Microsoft AppSource
Availability underscores the company’s continued commitment to offer a unified approach to migrate, manage, and…